The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant Novartis is in first place with a EUR 2.6 billion turnover, a full 89 percent of which came from the retail market. In second place is local champion Sanofi with a turnover of EUR 1.7 billion, followed by generics specialists Mylan with EUR 1.6 billion.
Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French…
In France, the ACOSS (central agency of social security funds) is in charge of the social security general…
This map shows the overall contribution of the pharmaceutical industry to the French economy, including number of…
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
A snapshot of the latest data on the French pharmaceutical industry from industry association LEEM, including…
The National Health Insurance Fund for employees (CNAMTS) is in charge of the health insurance branch of the Social…
The Top Five countries in Europe for pharma production. All located in Western Europe, Switzerland punches well…
The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest…
The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical…